The U.S. Food and Drug Administration (FDA) has intensified its enforcement actions against telehealth companies, issuing warning letters to 30 firms for allegedly marketing compounded formulations...
An investigation has revealed a concerning trend: counterfeit versions of an experimental weight loss drug, known as the ‘Godzilla’ of weight loss jabs, are being sold...
Eli Lilly has announced the results of its third phase 3 trial for the oral weight-loss medication orforglipron, paving the way for regulatory submissions worldwide. In...
